8-KOther EventsExhibits & Filings

Cencora, Inc. 8-K Report, Corporate Update (Oct 2, 2007)

Filed October 2, 2007For Securities:COR

Summary

Cencora, Inc. (formerly AmerisourceBergen Corporation) announced the completion of its acquisition of Bellco Health on October 1, 2007. This strategic move involved the purchase of a privately held pharmaceutical distributor for approximately $190 million in cash. The acquisition is expected to bolster Cencora's distribution capabilities and market presence in the branded and generic pharmaceutical sectors. Investors should note that this filing is primarily an announcement of a completed transaction rather than a detailed financial report. The acquisition of Bellco Health represents a significant cash outflow for Cencora, and while the immediate impact on earnings is not detailed in this 8-K, it signals the company's intent to grow through strategic acquisitions. Further details on the financial implications and integration of Bellco Health would likely be found in subsequent SEC filings and earnings reports.

Key Highlights

  • 1Cencora, Inc. completed the acquisition of Bellco Health on October 1, 2007.
  • 2The purchase price for Bellco Health was approximately $190 million in cash.
  • 3Bellco Health is a privately held distributor of branded and generic pharmaceuticals.
  • 4This acquisition is reported as an 'Other Event' under Item 8.01 of the 8-K filing.
  • 5The news release detailing the acquisition is attached as Exhibit 99.1.
  • 6The filing confirms the company's former name was AmerisourceBergen Corporation.

Frequently Asked Questions

This 8-K filing serves to officially announce the completion of Cencora, Inc.'s acquisition of Bellco Health, providing a key update for investors about a significant business transaction.

Cencora paid approximately $190 million in cash to acquire Bellco Health.

Bellco Health is a privately held distributor of both branded and generic pharmaceuticals.

This 8-K filing primarily announces the event. More detailed information regarding the financial implications, integration, and impact on Cencora's financial performance would typically be found in subsequent quarterly (10-Q) or annual (10-K) filings, as well as earnings releases.